Zepp Health (NYSE:ZEPP) Stock Price Down 6.9% - Should You Sell?

Key Points

• Zepp Health's stock price decreased by 6.9% on Thursday, trading as low as $44.22, with a significant decline in trading volume.
• Analysts have mixed opinions on Zepp Health, with one "buy" rating and one "sell" rating, resulting in an average price target of $60.23.
• Recently, Ariose Capital Management bought 27,717 shares of Zepp Health, making it a notable investment in their portfolio.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report)'s stock price was down 6.9% during mid-day trading on Thursday . The company traded as low as $44.22 and last traded at $45.50. Approximately 112,408 shares traded hands during mid-day trading, a decline of 61% from the average daily volume of 284,972 shares. The stock had previously closed at $48.88.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ZEPP. Fundamental Research set a $60.23 price objective on shares of Zepp Health and gave the company a "buy" rating in a research report on Tuesday, August 26th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Zepp Health in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Zepp Health to a "hold" rating in a research note on Saturday, August 16th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $60.23.

Zepp Health Stock Down 7.1%

The stock has a fifty day moving average price of $47.41 and a 200-day moving average price of $20.52. The firm has a market cap of $658.18 million, a PE ratio of -9.40 and a beta of 1.32. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10.

Hedge Funds Weigh In On Zepp Health

An institutional investor recently bought a new position in Zepp Health stock. Ariose Capital Management Ltd purchased a new position in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 27,717 shares of the company's stock, valued at approximately $1,269,000. Zepp Health makes up approximately 0.4% of Ariose Capital Management Ltd's portfolio, making the stock its 27th largest position. Ariose Capital Management Ltd owned approximately 0.19% of Zepp Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 52.61% of the company's stock.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.